Efficacy and safety of three dose regimens of agomelatine versus placebo given once a day for 6 weeks in out-patients suffering from moderate to severe major depressive disorder

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2010
This article has no abstract
Epistemonikos ID: 052f95c90aab8c37dc21b29f0406b92efeab752c
First added on: Jan 16, 2025